Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
TAG Mail 2 September 2015 TAG MEETINGS Nil TAG ACTIVITIES **Life Saving Drugs Register - A reminder for hospitals who have not completed the Life Saving Drugs Register survey (Antidotes) to enable an update of information available on the NSWTAG website. The link to the survey is: https://www.surveymonkey.com/r/GSC2JFD - The Life Saving Drugs Register survey (Antivenoms) will be sent to hospital contacts today. It would be appreciated if the survey could be completed by no later than 18 September 2015, to allow for the register to be updated coinciding with the approaching snake bite and spider bite season. The link to the survey is: https://www.surveymonkey.com/r/2015antivenom TAG WEBSITE Nil REPORTS AND PUBLICATIONS – AUSTRALIA **Australian Institute of Health and Welfare Trends in hospitalised injury, Australia: 1999–00 to 2012–13 http://www.aihw.gov.au/publication-detail/?id=60129552564 **NSW Health - Changes to prescribing and dispensing of Botulinum toxin and growth hormone http://www0.health.nsw.gov.au/policies/ib/2015/IB2015_049.html - Standards for paediatric intravenous fluids http://www0.health.nsw.gov.au/policies/gl/2015/GL2015_008.html **TGA - List of Evaluated Registered Complimentary Medicines – Updated 27 August 2015 http://www.tga.gov.au/list-evaluated-registered-complementary-medicines - Medical Devices and IVDs: Cancellations of certain devices within an entry https://www.tga.gov.au/medical-devices-and-ivds-cancellations-certain-devices-within-entry REPORTS AND PUBLICATIONS – INTERNATIONAL **NICE Guidance List - Bevacizumab for treating relapsed, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal) http://www.nice.org.uk/guidance/ta353 - Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism http://www.nice.org.uk/guidance/ta354 - Vedolizumab for treating moderately to severe active Crohn’s disease after prior therapy http://www.nice.org.uk/guidance/ta352 **CADTH - Antidepressants in Elderly Patients with Depression and Dementia: A Review of Clinical Effectiveness and Guidelines https://www.cadth.ca/sites/default/files/pdf/htis/aug-2015/RC0689%20%20Antidepressants%20in%20the%20Elderly%20Final.pdf - Long-acting Opioids for Chronic Non-cancer Pain: A Review of the Clinical Efficacy and Safety https://www.cadth.ca/sites/default/files/pdf/htis/aug-2015/RC0698%20Opioids%20Final.pdf **EMA - EPAR added: Phenylephrine/ketorolac eye drops (Omidria) http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003702/human_med_00 1888.jsp&mid=WC0b01ac058001d124 - EPAR added: Dinutuximab (Unituxin) for neuroblastoma http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002800/human_med_00 1891.jsp&mid=WC0b01ac058001d124 - EPAR added: Sebelipase alfa (Kanuma) for lysosomal acid lipase deficiency. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004004/human_med_00 1896.jsp&mid=WC0b01ac058001d124 **FDA - FDA approves evolocumab (Repatha) to treat certain patients with high cholesterol http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm460082.htm - FDA extends use of eltrombopag (Promacta) in young children with rare blood disorder http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm459430.htm -FDA approves new indication for eslicarbazepine as monotherapy for partial-onset seizures http://www.biospace.com/News/sunovion-pharmaceuticals-inc-announces-fda/389559/source=MoreNews **MHRA -Early access to medicines scheme (EAMS) scientific opinion: sacubitril/valsartan https://www.gov.uk/government/publications/early-access-to-medicines-scheme-eams-scientificopinion-sacubitrilvalsartan **UKMi -Prescribing Outlook New Medicines: horizon scanning for entries for new medicines, line extensions or new formulations, including over 20 biosimilar formulations http://www.ukmi.nhs.uk/filestore/ukmianp/2015PrescribingOutlook-NewMedicines-FINAL.pdf MEDICATION SAFETY **AHRQ - Reducing errors through discharge medication reconciliation by pharmacy services. http://www.psnet.ahrq.gov/resource.aspx?resourceID=29288 - Prevalence, nature, severity and risk factors for prescribing errors in hospital inpatients: prospective study in 20 UK hospitals http://www.psnet.ahrq.gov/resource.aspx?resourceID=29168 **Health Canada -Health Product InfoWatch, August 2015 includes information on paracetamol and liver injury, ferumoxytol, clopidogrel and repaglinide interaction and a review article of rivaroxaban and liver injury http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2015-08-eng.php#review **FDA - DPP-4 Inhibitors for Type 2 diabetes may cause severe joint pain http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm46023 8.htm **ISMP - ISMP comments on BD syringe potency issue http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=117 - Draft Guidelines for the Safe Communication of Electronic Medication Information http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=116 **TGA - Medical Devices Safety Update Volume 3, Number 5, September 2015 http://www.tga.gov.au/publication-issue/medical-devices-safety-update-volume-3-number-5-september-2015 -Incidents have been reported of unsatisfactory spinal block with the use of Marcain Spinal 0.5% Heavy (bupivacaine) by Astra Zeneca. At present there is no safety notice or drug withdrawal notice from either the Therapeutics Goods Administration (TGA) or the sponsor Astra Zeneca. The TGA is aware of a number of reports of the problem and is monitoring the situation. A notice has been posted on the College of Anaesthetists website. Your assistance is requested to forward this information to all relevant staff and to remind staff to notify the TGA if they experience unsatisfactory spinal block with this product at: http://www.tga.gov.au/reporting-problems PAPERS OF INTEREST ** American Journal of Medical Quality -Unit-Based Interventions to Improve Teamwork and Patient Safety http://ajm.sagepub.com/content/30/5?etoc -Reporting of Health Care–Associated Infections http://ajm.sagepub.com/content/30/5?etoc -Predictors of 30-Day Hospital Readmission Following Ischemic and Hemorrhagic Stroke http://ajm.sagepub.com/content/30/5?etoc **Annals of Internal Medicine -How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation http://annals.org/article.aspx?articleid=2362311 **Australian Health Review -Should fee-for-service be for all guideline-advocated acute coronary syndrome (ACS) care? Observations from the Snapshot ACS http://www.publish.csiro.au/index.cfm?act=view_file&file_id=AH14153.pdf&utm_source=AHHA+Events+%26 +Publications+Newsletter&utm_campaign=299e94b76eAustralian+Health+Review+39%281%29&utm_medium=email&utm_term=0_a68a5446bc-299e94b76e245411241 -Healthcare resource use in patients of the Australian Transition Care Program Study http://www.publish.csiro.au/index.cfm?act=view_file&file_id=AH14054.pdf&utm_source=AHHA+Events+%26 +Publications+Newsletter&utm_campaign=299e94b76eAustralian+Health+Review+39%281%29&utm_medium=email&utm_term=0_a68a5446bc-299e94b76e245411241 -Exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand http://www.publish.csiro.au/index.cfm?act=view_file&file_id=AH14122.pdf&utm_source=AHHA+Events+%26 +Publications+Newsletter&utm_campaign=299e94b76eAustralian+Health+Review+39%281%29&utm_medium=email&utm_term=0_a68a5446bc-299e94b76e245411241 -Can clinical supervision sustain our workforce in the current healthcare landscape? Findings from a Queensland study of allied health professionals http://www.publish.csiro.au/index.cfm?act=view_file&file_id=AH14183.pdf&utm_source=AHHA+Events+%26 +Publications+Newsletter&utm_campaign=299e94b76eAustralian+Health+Review+39%281%29&utm_medium=email&utm_term=0_a68a5446bc-299e94b76e245411241 **BMJ Quality and Safety -Development of the Quality Improvement Minimum Quality Criteria Set (QI-MQCS): a tool for critical appraisal of quality improvement intervention publications http://qualitysafety.bmj.com/content/early/2015/08/26/bmjqs-2014-003151.full.pdf+html -How to build up the actionable knowledge base: the role of ‘best fit’ framework synthesis for studies of improvement in healthcare http://qualitysafety.bmj.com/content/early/2015/08/25/bmjqs-2014-003642.full.pdf+html -Statistical process control and interrupted time series: a golden opportunity for impact evaluation in quality improvement http://qualitysafety.bmj.com/content/early/2015/08/27/bmjqs-2014-003756.extract -A cluster-randomised quality improvement study to improve two inpatient stroke quality indicators http://qualitysafety.bmj.com/content/early/2015/08/24/bmjqs-2015-004188.abstract **Circulation: Cardiovascular Quality and Outcomes -Comparison of the Abilities of Summary Measures of International Normalized Ratio Control to Predict Clinically Relevant Bleeding http://circoutcomes.ahajournals.org/content/early/2015/09/01/CIRCOUTCOMES.115.001768.abstract **Diabetes care -A Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes http://care.diabetesjournals.org/content/early/2015/08/28/dc15-0811.abstract **European Heart Journal -Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv443 -Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv456 -2015 ESC Guidelines for the diagnosis and management of pericardial diseases http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv318 -2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv320 -2015 ESC Guidelines for the management of infective endocarditis http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv319 -2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv316 -2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension http://eurheartj.oxfordjournals.org/content/early/2015/08/28/eurheartj.ehv317 ** European Journal of Hospital Pharmacy -A study of Foundation Year doctors’ prescribing in patients with kidney disease at a UK renal unit: a comparison with other prescribers regarding the frequency and type of errors http://ejhp.bmj.com/content/22/5/291.abstract -The evolution of European Medicines Agency drug approval: the adaptive licensing http://ejhp.bmj.com/content/early/2015/08/21/ejhpharm-2015-000740.full.pdf+html -Pharmacist intervention in a psychiatric setting http://ejhp.bmj.com/content/22/5/280.abstract -Pharmacist intervention in pain management following heart surgery http://ejhp.bmj.com/content/22/5/306.abstract **Heart -Acute myocardial infarction and influenza: a meta-analysis of case–control studies http://heart.bmj.com/content/early/2015/08/26/heartjnl-2015-307691.abstract Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis http://heart.bmj.com/content/early/2015/08/28/heartjnl-2015-307930.abstract **JAMA - Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation http://jama.jamanetwork.com/article.aspx?articleid=2431702 **JAMA Internal Medicine - Variability in Antibiotic Use Across Nursing Homes and the Risk of Antibiotic-Related Adverse Outcomes for Individual Residents http://archinte.jamanetwork.com/article.aspx?articleid=2337257 **JAMIA - An algorithm to identify medication nonpersistence using electronic pharmacy databases http://jamia.oxfordjournals.org/content/22/5/957 - Cross-vendor evaluation of key user-defined clinical decision support capabilities: a scenario-based assessment of certified electronic health records with guidelines for future development http://jamia.oxfordjournals.org/content/22/5/1081 - Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes http://jamia.oxfordjournals.org/content/22/5/1094 - Report of the AMIA EHR-2020 Task Force on the status and future direction of EHRs http://jamia.oxfordjournals.org/content/22/5/1102 **Journal of Clinical Oncology -Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.62.1342.abstract -Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.61.6474.abstract **Journal of Pediatrics Comparative Effectiveness of Dexamethasone versus Prednisone in Children Hospitalized with Asthma http://www.jpeds.com/article/S0022-3476(15)00676-9/abstract **Journal of The National Cancer Institute -Impact of Fertility Concerns on Tamoxifen Initiation and Persistence http://jnci.oxfordjournals.org/content/107/10/djv202.abstract **NEJM - Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes http://www.nejm.org/doi/full/10.1056/NEJMoa1507854?query=featured_home - Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension http://www.nejm.org/doi/full/10.1056/NEJMoa1413687 - Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation http://www.nejm.org/doi/full/10.1056/NEJMoa1501035 **The Lancet Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(15)00216-1/abstract **The Lancet Oncology -Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(15)00246-6/abstract CONSULTATIONS ** ACSQHC Consultation: Version 2 of the National Safety and Quality Health Service (NSQHS) Standards http://www.safetyandquality.gov.au/our-work/accreditation-and-the-nsqhs-standards/current-consultations/ Closes 30 October 2015 **TGA - Current consultation: Proposed Amendments to the Poisons Standard: bismuth oxychloride, naproxen, pantoprazole, paracetamol/ibuprofen combination, piracetam. Due 3 rd September 2015. https://www.tga.gov.au/consultation-invitation/consultation-proposed-amendments-poisons-standardmedicines OTHER NEWS Clinical Excellence Commission Medication Safety Project Officers - advertised internal to NSW Health with closing date Friday 11 Sep 2015 Contact: Nina Muscillo, Manager, Medication Safety, CEC; Phone: 9269 5585 [email protected] UPCOMING EVENTS (new additions in bold) **CEC NSW Antimicrobial Stewardship Forum, Sydney, 4th September http://www.cec.health.nsw.gov.au/__data/assets/pdf_file/0010/279982/Flyer-and-Program-for-AMS-Forum2015.pdf **ADMA 11th Annual National Conference: Count me in- Partnerships in chronic care 10th-11th September 2015, Brisbane Convention Centre, Queensland http://www.adma.org.au/images/Conference_Flyer_2015.pdf **ISMP Medication Safety intensive, 17-18 September 2015, Bellevue WA, USA https://www.ismp.org/orderforms/msi_registrations.asp NSW Medicines Information Centre one-day Search Skills Workshop on Saturday September 19th. Cost: $ 275. CPD: Non-accredited. 6 Group 1 CPD points, or 12 Group 2 CPD points (with assessment). Online registration: https://svhs.org.au/home/research-education/education/courses-workshops-andconferences/allied-health/medicines-information-searching-skills-seminar For more information contact the MIC on (02) 8382 3047 or [email protected] ** Monash University Hot topics in healthy ageing: Research evidence, clinical skills and tools to manage an ageing population, 21 September 2015, Melbourne http://www.med.monash.edu.au/sphpm/creps/seminars.html **4th World Congress of Clinical Safety 2015, 28-30 September 2015, Vienna http://www.iarmm.org/4WCCS/ **AHRQ Agency for Healthcare Research and Quality (AHRQ) research conference, 4–6 October, 2015, Crystal City, Virginia USA Health care research and policy sessions on improving quality, safety, access and value in health care http://www.ahrq.gov/news/events/conference/index.html **ISQUA Building Quality and Safety into the Healthcare System, 4-7 October 2015, Doha, Qatar. http://www.isqua.org/conference/doha-2015/registration-2015?utm_source=Conference++Registration+Open+-+March+2015&utm_campaign=Conference+-+Reg+Open++March+2015&utm_medium=email **National Hospital Procurement Conference, 29-30 October 2015, Sydney http://www.informa.com.au/conferences/health-care-conference/national-hospital-procurementconference?utm_source=E-Pre&utm_medium=email&utm_campaign=P15a21 ** APSA-ASCEPT 2015 Scientific Meeting, 28 November- 2 December 2015, Hobart Abstract submission deadline: Friday 11 September 2015. http://www.asceptasm.com/2015-annual-scientific-meeting/program-2015/ **SHPA Medicines Management 2015, 3-6 December 2015, Melbourne Convention Centre. http://mm2015shpa.com/ **APAMT (Asia Pacific Association of Medical Toxicology) ‘Remote, Resource and Retrieval Challenges in Toxicology’, 1-4 December 2015, Perth http://www.apamt2015.com/ **EAHP 21st Congress of the EAHP (European Association of Hospital Pharmacists), 16-18 March 2016, Vienna, Austria. ‘Hospital pharmacists taking the lead – partnerships and technologies’ http://www.eahp.eu/congresses